Center for Global Health Faculty

Academic Degrees

Departmental Address

Contact Information

Email:

kdooley1+jhmi.edu

Phone:

410-287-0517

Fax:

410-614-9978

Keywords

Clinical pharmacology of anti-infective agents; Evaluation of new drug regimens for the treatment of tuberculosis and co-treatment of TB and HIV

Selected Publications

• Dooley, K.E., Golub, J., Goes, F.S., Merz, W.G., and Sterling, T.R.  Empiric Treatment of Community-Acquired Pneumonia with Fluoroquinolones, and Delays in the Treatment of Tuberculosis.  Clinical Infectious Diseases 34: 1607-12, 2002.  Pub Med Reference
  
  
• Dooley, K.E., Flexner, C., and Andrade, A.S.  Drug Interactions Involving Combination Antiretroviral Therapy and Other Anti-Infective Agents: Repercussions for Resource-Limited Countries.  Journal of Infectious Diseases 198: 948-61, 2008.  Pub Med Reference
  
  
• Dooley, K.E., Flexner, C., Hackman, J., Peloquin, C., Nuermberger, E., Chaisson, R.E., and Dorman, S.E.  Repeated Administration of High-Dose Intermittent Rifapentine Reduces Rifapentine and Moxifloxacin Plasma Concentrations. Antimicrobial Agents and Chemotherapy 52: 4037-42, 2008.  Pub Med Reference
  
  
• Ribiero, S., Dooley, K.E., Hackman, J., Loredo, C., Efron, A., Chaisson, R.E. Conde, M.B., Boechat, N., and Dorman, S.E.  T-SPOT.TB Responses DuringTreatment of Pulmonary Tuberculosis.  BMC Infectious Diseases 9: 23, 2009.  Pub Med Reference
  
  
• Dooley, K.E., Tang, T., Golub, J., Dorman, S.E., and Cronin, W. Imparct of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis. American Journal of Tropical Medicine and Hygiene 80: 634-9, 2009. Pub Med Reference
• Dooley, K.E. and Chaisson, R.E.  Tuberculosis and Diabetes Mellitus: The Convergence of Two Epidemics.   Lancet Infectious Diseases 9: 737-746, 2009.  Pub Med Reference
  
  
• Matteelli, A., Carvalho, A.C.C., Dooley, K.E., and Kritski, A.  TMC207: the first compound of a new class of potent antituberculosis drugs. Future Medicine, 5: 849-58, 2010.  Pub Med Reference
  
  
• Almeida, D., Converse, P.J., Ahmad, Z., Dooley, K.E., Nuermberger, E.L., Grosset, J. Activities of rifampin, rifapentine and clarithromycin, alone and in combination, against Mycobacterium ulcerans disease in mice. PLoS Neglected Tropical Diseases, 5: e933, 2011.  Pub Med Reference
  
  
• Burman, W., Dooley, K.E., Nuermberger, E. The rifamycins: renewed interest in an old drug class.  In Progress in Respiratory Research, Volume 40, Chapter title: "Antituberculosis Chemotherapy", edited by Peter Donald and Paul van Helden, Karger AG - Medical and Scientific Publishers.
  
  
• Dooley, K.E., Lahlou, O., Ghali, I., Kudsen, J., Elmessaoudi, M.D., Cherkaoui, I., El Aouad, R. Risk Factors for Tuberculosis Treatment Failure, Default, or Relapse and Outcomes of Retreatment in Morocco. BMC Public Health 11:140, 2011.  Pub Med Reference